Transradial Closure Devices Market Trends

  • Report ID: 4346
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Transradial Closure Devices Market Trends

Growth Drivers

  • Worldwide Spike in Coronary Artery Disease (CAD) – Coronary artery disease is one such disease that affects the blood-supplying arteries. It is also referred to as ischemic heart disease (IHD). One or more coronary arteries become blocked or progressively narrow with CAD. The most frequent symptom of this inner condition is angina, which causes chest pain. In most cases, CAD results in a heart attack or other issues such as heart failure or arrhythmia. The surge in the number of people suffering from CAD is expected to escalate the global transradial closure devices market in the forecasted period. It is observed that CAD affected approximately 125 million people (1,658 per 100,000), or approximately 2% of the world's population, until 2020. CAD has claimed the lives of more than 9 million people worldwide. Furthermore, the prevalence of CAD is increasing. The current prevalence rate of 1,658 per 100,000 population is expected to increase to 1,849 by 2030 on a global scale.

  • Growing Prevalence of Strokes – For instance, over 12.4 million new strokes occur each year, with people aged 15 to 48 accounting for more than 16% of all stroke cases in the world.

  • Escalation of Lifestyle Diseases – Owing to their busy lifestyles, people are propelled to eat packaged food and minimize their physical activity. As a result, many diseases such as obesity, thyroid, heart disease, high cholesterol levels, and others, which in turn are anticipated to increase the demand for transradial closure devices in diagnosing and treating such illnesses. It was observed that until 2018, around 78% of the global population was directly affected by lifestyle diseases.

  • Rising Cholesterol Level Among the Global Population – As per the Centers for Disease Control and Prevention (CDC), till 2022, high cholesterol (total blood cholesterol 200 mg/dL) have been affecting approximately 38% of adults in the United States.

  • Worldwide Increasing Healthcare Expenditure - According to data released by the World Bank, global healthcare expenditure increased to 9.83% in 2019 from 9.7% in 2018.

Challenges

  • Inadequate Knowledge of Proper Handling of Devices. Improper handling of transradial closure devices may result in radial artery occlusion. It is the most frequent post-procedural complication of TRA, restricting the use of the same radial artery for future procedures.
  • High Cost of Transradial Closure Devices – The costs of transradial closure devices are considerably high owing to their technology and advanced features. As a result, the population with a middle income is anticipated to push further away from adopting transradial closure devices owing to a lack of funds. This trend is expected to pose a threat to market growth during the assessment period.
  • Insufficiency of Knowledge About the Procedure

Transradial Closure Devices Market: Key Insights

Base Year

2022

Forecast Year

2023-2035

CAGR

~9%

Base Year Market Size (2022)

~ USD 230 Million

Forecast Year Market Size (2035)

~ USD 420 Million

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Base Year

2024

Forecast Year

2025-2037

CAGR

9.6%

Base Year Market Size (2024)

USD 276.03 million

Forecast Year Market Size (2037)

USD 908.85 million

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4346
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of transradial closure devices is assessed at USD 320.06 million.

The transradial closure devices market size was over USD 276.03 million in 2024 and is projected to reach USD 908.85 million by 2037, witnessing around 9.6% CAGR during the forecast period i.e., between 2025-2037. Worldwide spike in coronary artery disease (CAD), growing prevalence of strokes, escalation of lifestyle diseases, and raising cholesterol levels will drive the market growth.

North America industry is likely to account for largest revenue share of 37% by 2037, driven by high prevalence of heart disease in the region along with the increasing geriatric population, and accessibility of advanced healthcare facilities.

The major players in the market are Medtronic plc, Teleflex Incorporated, Merit Medical Systems, Inc., Abbott Laboratories, Fisher & Paykel Healthcare Corporation Limited, Beijing Demax Medical Technology Co., Ltd., Semler Technologies, Inc., Endocor GmbH, Morris Innovative, Inc., Transluminal Technologies, LLC
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample